G. Jevons

400 total citations
7 papers, 279 citations indexed

About

G. Jevons is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, G. Jevons has authored 7 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in G. Jevons's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). G. Jevons is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). G. Jevons collaborates with scholars based in United Kingdom. G. Jevons's co-authors include Robert A. Wise, D. Honeybourne, J. M. Andrews, Ashish Soman, J. P. Ashby, Brian C. Cunningham, N. Brenwald, J. M. Andrews, Stephen Hawser and A.P. Fraise and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy.

In The Last Decade

G. Jevons

7 papers receiving 266 citations

Peers

G. Jevons

EPIDE

PHARM

MM

ID

PRM

Kalpana B. Patel United States

Holly M. Mattoes United States

J Bauchet France

Marlynne Micalizzi United States

Manickam Rangaraju France

Sheila Duncan United States

Firas Koura United States

Cristina de la Calle Spain

Wen‐Sen Lee Taiwan

Carlos Bergallo Argentina

Kalpana B. Patel United States

G. Jevons

191 ×1.0

EPIDE

198 ×1.2

PHARM

117 ×1.0

MM

85 ×1.3

ID

37 ×1.0

PRM

Citations per year, relative to G. Jevons G. Jevons (= 1×) peers Kalpana B. Patel

Countries citing papers authored by G. Jevons

Since Specialization

Citations

This map shows the geographic impact of G. Jevons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Jevons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Jevons more than expected).

Fields of papers citing papers by G. Jevons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Jevons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Jevons. The network helps show where G. Jevons may publish in the future.

Co-authorship network of co-authors of G. Jevons

This figure shows the co-authorship network connecting the top 25 collaborators of G. Jevons. A scholar is included among the top collaborators of G. Jevons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Jevons. G. Jevons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Andrews, J., D. Honeybourne, J. P. Ashby, et al.. (2007). Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men. Journal of Antimicrobial Chemotherapy. 60(3). 677–680. 26 indexed citations

2.

Andrews, J. M., G. Jevons, N. Brenwald, & A.P. Fraise. (2004). Susceptibility testing Pasteurella multocida by BSAC standardized methodology. Journal of Antimicrobial Chemotherapy. 54(5). 962–964. 2 indexed citations

3.

Andrews, J. M., et al.. (2000). A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998. Journal of Antimicrobial Chemotherapy. 45(3). 285–293. 31 indexed citations

4.

Andrews, J. M., J. P. Ashby, G. Jevons, & Robert A. Wise. (1999). Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria. Journal of Antimicrobial Chemotherapy. 44(6). 819–822. 20 indexed citations

5.

Soman, Ashish, D. Honeybourne, J. M. Andrews, G. Jevons, & Robert A. Wise. (1999). Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy. 44(6). 835–838. 132 indexed citations

6.

Honeybourne, D., J. M. Andrews, Brian C. Cunningham, G. Jevons, & Robert A. Wise. (1999). The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy. 43(1). 153–155. 11 indexed citations

7.

Andrews, J. M., D. Honeybourne, G. Jevons, et al.. (1997). Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy. 40(4). 573–577. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact